OpenIcon research & analysis
About

Information Technology

Stocks Covered
Finance &
Economics
Press

Foreseeing value & Offering insight

Seeking Alpha articles by William P. Meyers

Recent and Popular:

Walgreens Aims For Rapid Growth [October 19, 2021]

Seagen Stock Is A Buy For Its Pipeline Value [September 15, 2021]

Bristol Myers Squibb Q2 2021 Shows Strenth And Value [July 29, 2021] at Seeking Alpha

Biogen's Case for Aduhelm [July 27, 2021 at Seeking Alpha]

Intuitive Surgical has a Good Q2 [July 22, 2021 @ Seeking Alpha]

Inovio Has 4 Sources Of Potential Value [June 2, 2021, Seeking Alpha]

Ionis: Price Slump Is An Opportunity To Buy The Pipeline [June 22, 2021, Seeking Alpha]

Agenus/Bristol Myers Squibb Deal Makes for a Strong Buy [May 28, 2021, Seeking Alpha]

Acceleron: Neutral On Stock Price Gains [April 5, 2021, Seeking Alpha]

Epizyme Comeback Is Likely, Price Makes It A Buy by William Meyers [March 32, 2020 @ Seeking Alpha]

Inovio VGX-3100 HPV Data Adds To Conviction [March 24, 2021 at Seeking Alpha]

Agenus A Buy On Coming 2021 Data, FDA Filings [March 15, 2021 at Seeking Alpha]

Gilead: A Hold Despite Cancer Advance, Remdesivir, Dividend [Seeking Alpha, May 11, 2021]

Biogen 2021: Two Paths Diverge [February 8, 2021 at Seeking Alpha]

Fate Therapeutics Jumped On Supportive Trial Data by William Meyers [December 18, 2020 Seeking Alpha]

Alnylam as a Strategic Investment by William Meyers [November 28, 2020 Seeking Alpha]

Inovio: Accumulate For The HPV And Brain Cancer Therapiesue [November 19, 2020 at Seeking Alpha]

Let Corporations Pay Some Taxes with Stock

Agenus: A Buy With iNKT Therapy, MK-4830 Milestone [November 13, 2020 at Seeking Alpha]

Ionis With Akcea: Still A Bargain [October 21, 2020 @ Seeking Alpha]

Why Celldex Has Been A Big Winner In 2020 October 1, 2020 @ Seeking Alpha

Agenus versus Seattle Genetics Cervical Cancer Results September 30, 2020 @ Seeking Alpha

Incyte FDA Approvals To Propel Future Growth [Seeking Alpha, September 18, 2020]

Dicerna Pharmaceuticals May Be the Best Value Among RNAi Companies [September 15, 2020 at Seeking Alpha]

Arrowhead Pharmaceuticals Is A Smart Long-Term Opportunity [September 11, 2020 at Seeking Alpha]

Amgen Still A Buy After Joining The Dow [September 5, 2020 @ Seeking Alpha]

Agios Pharmaceuticals A Buy For Tibsovo, Mitapivat September 1, 2020 at Seeking Alpha

Star Bulk Reels From Trade Recession, Could Soar With Recovery [June 2, 2020 @ Seeking Alpha]

Inovio's Wild Ride and Real Value [March 25, 2020 @ Seeking Alpha]

Amgen's AMG 510 Targeted Cancer Therapy [October 4, 2019 @ Seeking Alpha]

Immune Checkpoint Inhibitors

Biotechnology stocks covered

Biotech Research Help page

The Accounting System: The New Money Cloud


Links to Quarterly Results Notes

Dissecting the Bull blog

Finance and Economics Commentary

Tipranks rating

 

(experimental): Random Stock Picker

Machine Understanding (AI)